GRI Bio, Inc. (GRI): Narx-foyda va o‘sish multiplikatori
GRI Bio, Inc. (GRI) avtoimmun patologiyalar uchun dori vositalarini ishlab chiqishga e'tibor qaratgan holda grantlar orqali daromad keltiradi. PEG koeffitsiyenti ushbu bosqichni vizuallashtiradi, bunda parametr qiymati 0.00 ga tengdir. Kompaniyaning salohiyati jigar fibrozini davolashga bo'lgan noelastik talabga asoslangan, intellektual mulk himoyasi va FDA ning qat'iy talablari esa yangi ishtirokchilar uchun kirishning sezilarli to'sig'ini yaratadi.
GRI Bio, Inc. (GRI) kompaniyasining tahliliy kesimlari
- narx va narxlar bo'yicha konsensus prognoz:
- birja kapitallashuvi ma'lumotlari:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Qarzning xususiy kapitalga nisbati GRI Bio, Inc.|GRI - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli majburiyatlarning kapitalga nisbati gribio.com|GRI - Kompaniyaning jamlangan qarzlari|Qarzning sof aktivlarga nisbati GRI Bio Corp|GRI - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli kredit va qarzlari GRI Bio|Oraliq qoplama koeffitsiyenti gribio.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
GRI - Sof daromad|Kutilayotgan sof daromad GRI Bio, Inc.|GRI - P/E multiplikatori|Kelajakdagi narxning foydaga nisbati GRI Bio Corporation|GRI - PEG multiplikatori|Kompaniyaning to‘liq qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati GRI Bio Corp|GRI - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|So'nggi o'n ikki oy davomida bitta aksiya uchun sof foyda GRI Bio|GRI - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi 12 oy davomida bitta aksiya uchun foydaning yillik o'sishi gribio.com|GRI - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun foyda o'sishining konsensus prognozi GRI Bio, Inc.
Kompaniyaning umumiy tahlili:GRI Bio, Inc.
Kambag' baholangan aktivlarni qidirish biznes qiymatini foyda dinamikasi bilan muvofiqlashtirishni talab qiladi, bu esa global surunkali patologiya bozoriga kengayish davrida NKT-hujayrali immunoterapiya segmentidagi GRI Bio, Inc. (GRI) uchun juda muhimdir. Foyda o'sish sur'atlariga nisbatan og'irlangan P/E bo'yicha 0.00 ning joriy qiymati PEG ko'rsatkichini aks ettiradi: agar ushbu ko'rsatkich birdan past bo'lsa, bozor kompaniyaning fundamental metrikalari kengayish sur'atlarini e'tiborsiz qoldirgan holda, uning potentsialini past baholamoqda.
GRI Bio, Inc. raqobatchilari
O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati argenx N.V.|Narxning foydaga va o‘sish sur’atiga nisbati BioNTech Group BNTX|ABVX - Narx-foyda va o‘sish multiplikatori|ADMA - Narxning foydaga va o‘sish sur’atiga nisbati|protagonist-inc.com (PTGX) - Narx-foyda va o‘sish multiplikatori|IMVT (Immunovant) - Narx-foyda va o‘sish multiplikatori|Kiniksa Pharmaceuticals, Ltd. (KNSA) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati Grifols Group|O‘sishni hisobga olgan narx-foyda koeffitsiyenti ADPT (Adaptive Biotechnologies Inc.)|PEG multiplikatori CLDX|AUPH - O‘sish sur’atiga tuzatilgan narx-foyda|PEG multiplikatori BCRX (BioCryst Pharmaceuticals)|Narxning sof foyda o‘sishiga nisbati Vera Therapeutics Inc|DNTH - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti PHVS (Pharvaris Pharma)|ABCL: PEG multiplikatori|TRML - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narx-foyda va o‘sish multiplikatori PGEN|PHAR: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori NKTR|Narxning foydaga va o‘sish sur’atiga nisbati UPB (Upstream Pharma)|PEG multiplikatori ZBIO (Zenas Biopharma Inc)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati immunome.com (IMNM)|GOSS - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atiga tuzatilgan narx-foyda KalVista Pharma|SEPN (Septerna Corp) - Narx-foyda va o‘sish multiplikatori|Pieris Corp - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|SVRA (Savara Inc.) - PEG multiplikatori|rigel.com (RIGL) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati AnaptysBio (ANAB)|Astria Therapeutics Inc - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori ENGN (enGene Bio)|RAPT - Narx-foyda va o‘sish multiplikatori|JBIO: Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati aclaristx.com ACRS|KYTX: PEG multiplikatori|Narxning sof foyda o‘sishiga nisbati Tiziana Life Sciences Ltd. TLSA|Narxning foydaga va o‘sish sur’atiga nisbati Cabaletta Bio, Inc|VTYX: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori THTX|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati avalotx.com|Narxning foydaga va o‘sish sur’atiga nisbati Eledon Pharmaceuticals, Inc. ELDN|AGEN (Agenus, Inc.) - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|Climb Bio, Inc. - PEG multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti ZURA (zurabio.com)|ATYR: PEG multiplikatori|Adagene Inc. (ADAG) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati ImageneBio|STTK: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Equillium, Inc. (EQ)|Narx-foyda va o‘sish multiplikatori connectbiopharm.com CNTB|PEG multiplikatori IMUX (Immunic)|PEG multiplikatori Atara Biotherapeutics, Inc. ATRA|IFRX: Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti XFOR (X4 Pharmaceuticals Inc.)|ACET: PEG multiplikatori|CELU - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati INmune Bio, Inc.|Narx-foyda va o‘sish multiplikatori barinthusbio.com (BRNS)|Narxning foydaga va o‘sish sur’atiga nisbati Kezar Life Sciences, Inc. (KZR)|Narx-foyda va o‘sish multiplikatori SAB Biotherapeutics Inc. SABS|Akari Therapeutics plc - Narx-foyda va o‘sish multiplikatori|PEG multiplikatori Enlivex Therapeutics Ltd ENLV|QTTB - Narxning foydaga va o‘sish sur’atiga nisbati|GOVX (geovax.com) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|EDSA: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda iBio Inc (IBIO)|CARM (Carisma Therapeutics Inc) - PEG multiplikatori|XTLB - Narxning sof foyda o‘sishiga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Bolt Biotherapeutics (BOLT)|HCWB (hcwbiologics.com) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori APVO (Aptevo Therapeutics Inc.)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati aimimmuno.com (AIM)|ADTX: Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti XRTX (XORTX Corp)|HIND: PEG multiplikatori|REVB (revbiosciences.com) - Narxning foydaga va o‘sish sur’atiga nisbati|INDP (Indaptus Therapeutics, Inc.) - PEG multiplikatori|Scinai Immunotherapeutics Ltd (SCNI) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati CalciMedica, Inc. (CALI)|AFMD - O‘sish sur’atiga tuzatilgan narx-foyda|Allakos - Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti HOOK|IGM Bio - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati iTeos Therapeutics Inc ITOS|Ocean Bio (OCEA) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sishni hisobga olgan narx-foyda koeffitsiyenti TCBP|THRD (Third Harmonic Bio) - PEG multiplikatori
